Agilus Diagnostics Launches Anti-MCV Antibody Test in Collaboration with Sebia to Enable Early RA Diagnosis
New Delhi, July 15, 2025 – Agilus Diagnostics, in collaboration with Sebia, has launched the Anti-MCV (anti–mutated citrullinated vimentin) antibody test in India. Developed by Sebia, this advanced diagnostic tool significantly enhances the early detection of rheumatoid arthritis (RA), especially in patients who test negative for conventional markers such as anti-CCP and rheumatoid factor (RF). Rheumatoid arthritis … Read more